Morbidity and mortality after esophagectomy following neoadjuvant chemoradiation.
about
Understanding Complete Pathologic Response in Oesophageal Cancer: Implications for Management and SurvivalMinimally invasive surgery for esophageal cancer: review of the literature and institutional experienceInduction therapy does not improve survival for clinical stage T2N0 esophageal cancer.Radiation dose does not influence anastomotic complications in patients with esophageal cancer treated with neoadjuvant chemoradiation and transhiatal esophagectomy.Neoadjuvant Chemoradiotherapy Improving Survival Outcomes for Esophageal Carcinoma: An Updated Meta-analysis.External validation of the Ferguson pulmonary risk score for predicting major pulmonary complications after oesophagectomy†.Using the Comprehensive Complication Index to Assess the Impact of Neoadjuvant Chemoradiotherapy on Complication Severity After Esophagectomy for Cancer.Localization of thoracic duct using heavily T2W MRI for intractable post-esophagectomy chylothorax-a case report.Assessment of short-term clinical outcomes following salvage esophagectomy for the treatment of esophageal malignancy: systematic review and pooled analysis.Neoadjuvant therapy for advanced esophageal cancer: the impact on surgical management.The effects of neoadjuvant therapy on morbidity and mortality of esophagectomy for esophageal cancer: American college of surgeons national surgical quality improvement program (ACS-NSQIP) 2005-2012.Perioperative chemotherapy versus neoadjuvant chemoradiotherapy for esophageal or GEJ adenocarcinoma: A propensity score-matched analysis comparing toxicity, pathologic outcome, and survival.Chylothorax after esophagectomy for esophageal cancer: risk factors and management.Pre- to postoperative coagulation profile of 307 patients undergoing oesophageal resection with epidural blockade over a 10-year period in a single hospital: implications for the risk of spinal haematoma.The impact of neoadjuvant chemoradiotherapy on perioperative outcomes, tumor pathology, and survival in clinical stage II and III esophageal cancer.Impact of a multidisciplinary standardized clinical pathway on perioperative outcomes in patients with oesophageal cancer.Endoscopic ultrasound staging for early esophageal cancer: Are we denying patients neoadjuvant chemo-radiation?Neoadjuvant Chemotherapy versus Chemoradiation Prior to Esophagectomy: Impact on Rate of Complete Pathologic Response and Survival in Esophageal Cancer Patients.Management and outcome of cervical versus intrathoracic manifestation of cervical anastomotic leakage after transthoracic esophagectomy for cancer.Impact of neoadjuvant chemoradiotherapy on postoperative course after curative-intent transthoracic esophagectomy in esophageal cancer patients.
P2860
Q26798220-78F484B8-9559-49B4-9A28-025D1B1C2C57Q27010074-A6C2CDD4-0188-4014-BE2E-6EAAED03653BQ34093235-BDE9B97C-A4E7-4B79-AA87-A9DB53D6DB36Q35206602-9642C711-452A-4FB1-937C-C32341F03403Q36221479-A9AC1E14-4CE5-4937-906F-1EA6542A4490Q36429589-C964126F-8F39-4921-B0D3-A11035332778Q37306494-119BC8CE-C600-424C-94D8-03EFC240FDE8Q37677585-03B541E6-3BD4-4A7A-8561-81625090710EQ38161349-346F3382-76FA-4966-9230-451F38BF3880Q38831243-D5FD8767-1F9F-4B96-8083-D0D433C1318AQ39215848-919F0BB7-5E81-4ADC-BE03-129069C330C4Q40305149-4C960B8A-6D0D-4776-BDD0-697C18904A2CQ40886000-AED2AAFD-AA28-403E-933A-BE8A60043F10Q42370490-E7B9FD2D-3101-49B0-9762-C340AA994384Q44987067-B7DA4C1F-6E85-4C56-9CC3-FB56A520169CQ46659706-635A88DA-23C4-46F8-84C1-691C31BADB7EQ47099330-8917E255-81EC-4D92-B3E7-51C8093A1129Q49726258-1F4DA781-8D0B-4097-9967-9F2FE883C317Q52984651-FA11821E-1ED8-441D-A019-E2937106CA41Q53127562-99FCB82F-2CB8-4DC9-AE0E-92CA77739FF0
P2860
Morbidity and mortality after esophagectomy following neoadjuvant chemoradiation.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Morbidity and mortality after esophagectomy following neoadjuvant chemoradiation.
@en
Morbidity and mortality after esophagectomy following neoadjuvant chemoradiation.
@nl
type
label
Morbidity and mortality after esophagectomy following neoadjuvant chemoradiation.
@en
Morbidity and mortality after esophagectomy following neoadjuvant chemoradiation.
@nl
prefLabel
Morbidity and mortality after esophagectomy following neoadjuvant chemoradiation.
@en
Morbidity and mortality after esophagectomy following neoadjuvant chemoradiation.
@nl
P2093
P1476
Morbidity and mortality after esophagectomy following neoadjuvant chemoradiation.
@en
P2093
Chuong D Hoang
Joseph B Shrager
Nicole T D'Arcy
Richard I Whyte
Robert E Merritt
P304
P356
10.1016/J.ATHORACSUR.2011.05.121
P407
P577
2011-09-25T00:00:00Z